Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mackie

Showing results (331-340 of 366) with videos related to

Pageof 37
Sort By:
British Journal of Haematology|August 1, 1989
A plasma inhibitor of platelet aggregation in patients with Lassa feverD Cummins, S P Fisher-Hoch, K J Walshe, et al.
British Journal of Haematology|June 8, 2004
Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attackDominick J H McCabe, Paul Harrison, Ian J Mackie, et al.
Singapore Medical Journal|June 3, 2011
Comparison of RIPASA and Alvarado scores for the diagnosis of acute appendicitisC F Chong, A Thien, A J Mackie, et al.
Haematologica|December 23, 2003
A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group StudyKerri L Davidson, Maureen B Devaney, Jane E Tighe, et al.
FEBS Letters|November 18, 2000
Evidence for the activation of PAR-2 by the sperm protease, acrosin: expression of the receptor on oocytesR Smith, A Jenkins, A Lourbakos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2005
Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosisD J H McCabe, P Harrison, I J Mackie, et al.
Anesthesia and Analgesia|December 1, 1996
Maintenance of therapeutic plasma aprotinin levels during prolonged cardiopulmonary bypass using a large-dose regimenE Bennett-Guerrero, J G Sorohan, S T Howell, et al.
Journal of Cardiothoracic and Vascular Anesthesia|February 21, 2002
Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypassMurray J Adams, Rebecca A Cardigan, Warwick A Marchant, et al.
Clinical and Experimental Pharmacology & Physiology|September 23, 2009
Proteinase-activated receptor-2 (PAR2) and mouse osteoblasts: regulation of cell function and lack of specificity of PAR2-activating peptidesSmitha R Georgy, Charles N Pagel, David M Wong, et al.
Annals of the Rheumatic Diseases|February 2, 2006
Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndromeB de Laat, R H W M Derksen, I J Mackie, et al.
Pageof 37

Showing results (331-340 of 366) with videos related to

Sort By:
Pageof 37
British Journal of Haematology|August 1, 1989
A plasma inhibitor of platelet aggregation in patients with Lassa feverD Cummins, S P Fisher-Hoch, K J Walshe, et al.
British Journal of Haematology|June 8, 2004
Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attackDominick J H McCabe, Paul Harrison, Ian J Mackie, et al.
Singapore Medical Journal|June 3, 2011
Comparison of RIPASA and Alvarado scores for the diagnosis of acute appendicitisC F Chong, A Thien, A J Mackie, et al.
Haematologica|December 23, 2003
A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group StudyKerri L Davidson, Maureen B Devaney, Jane E Tighe, et al.
FEBS Letters|November 18, 2000
Evidence for the activation of PAR-2 by the sperm protease, acrosin: expression of the receptor on oocytesR Smith, A Jenkins, A Lourbakos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2005
Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosisD J H McCabe, P Harrison, I J Mackie, et al.
Anesthesia and Analgesia|December 1, 1996
Maintenance of therapeutic plasma aprotinin levels during prolonged cardiopulmonary bypass using a large-dose regimenE Bennett-Guerrero, J G Sorohan, S T Howell, et al.
Journal of Cardiothoracic and Vascular Anesthesia|February 21, 2002
Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypassMurray J Adams, Rebecca A Cardigan, Warwick A Marchant, et al.
Clinical and Experimental Pharmacology & Physiology|September 23, 2009
Proteinase-activated receptor-2 (PAR2) and mouse osteoblasts: regulation of cell function and lack of specificity of PAR2-activating peptidesSmitha R Georgy, Charles N Pagel, David M Wong, et al.
Annals of the Rheumatic Diseases|February 2, 2006
Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndromeB de Laat, R H W M Derksen, I J Mackie, et al.
Pageof 37